Abbonarsi

Superiority of linear-array EUS over MRCP in diagnosing pancreas divisum: evidence from a multicenter retrospective study in Oriental cohorts (with video) - 15/07/25

Doi : 10.1016/j.gie.2024.12.033 
Yuqing Mao, MD 1, , Jianbo Ni, MD 1, 2, , Kui Peng, MD 1, , Zhonggui Yu, MD 3, Shengzheng Luo, MD 1, Youchen Xia, MD 1, Sengwang Fu, MD 1, Ying Qu, PhD 1, Kai Xu, MD 1, Lungen Lu, MD 1, Xiaoyuan Gong, MBBS 1, Ning Zhong, MD, PhD 4, , Baiwen Li, MD, PhD 1, 2,
1 Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 
2 Shanghai Key Laboratory of Pancreatic Diseases, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 
3 Department of Gastroenterology, Huizhou First Hospital, Guangzhou Province, Guangzhou 
4 Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, China 

Corresponding author: Baiwen Li, MD, PhD, Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, No. 650 New Songjiang Road, Shanghai, 200080, China.Department of GastroenterologyShanghai General HospitalShanghai Jiaotong University School of MedicineNo. 650 New Songjiang RoadShanghai200080ChinaNing Zhong, MD, PhD, Department of Gastroenterology, Qilu Hospital, Shandong University, No. 107 Wenhua West Road, Lixia District, Jinan City, Shandong Province, China.Department of GastroenterologyQilu HospitalShandong UniversityNo. 107 Wenhua West RoadLixia DistrictJinan CityShandong ProvinceChina

Abstract

Background and Aims

Pancreas divisum (PD) is the most common developmental anatomic variant of pancreatic duct. The published data on the accuracy of the detection of PD by means of linear-array endoscopic ultrasound (L-EUS) are limited. This study aimed to assess the diagnostic accuracy of L-EUS compared with magnetic resonance cholangiopancreatography (MRCP) for identifying PD.

Methods

Patients who underwent L-EUS for pancreaticobiliary indications and subsequently received endoscopic retrograde pancreatograghy (ERP) treatment were retrospectively evaluated from January 2019 to July 2023.

Results

A total of 1378 patients from 3 tertiary centers were included, of which 120 were diagnosed with PD, as confirmed with the use of ERP, yielding an endoscopic detection rate of 8.7%. L-EUS exhibited a high sensitivity of 90.8% (95% confidence interval [CI], 85.7%-96.0%) and an overall accuracy of 99% (95% CI, 98.5%-99.5%) for the diagnosis of PD. These figures were significantly superior to those of MRCP, which showed a sensitivity of 48.4% (95% CI, 38.1%-58.6%) and an accuracy of 95.4% (95% CI, 93.5%-96.3%) (P < .001). Furthermore, the area under the receiver operating characteristic curve (AUC) for PD diagnosis was notably higher for L-EUS (95.7%) compared with MRCP (74.1%) (P < .001). Consistency testing revealed that L-EUS had an excellent kappa value of 0.934, compared with the reference standard of 0.621. Univariate logistic regression analysis identified the presence of pancreatic duct stones, chronic pancreatitis, and severe pancreatitis as potential factors leading to diagnostic failure in detecting PD with the use of L-EUS. Subsequent multivariate logistic regression analysis confirmed that the presence of pancreatic duct stones (odds ratio [OR], 5.627; 95% CI, 1.391-22.765) and severe pancreatitis (OR, 12.818; 95% CI, 2.280-72.061) were significantly associated with increased odds of L-EUS diagnostic failure for PD.

Conclusions

Our study conclusively demonstrates that L-EUS significantly outperforms MRCP in diagnosing PD. L-EUS exhibits markedly higher sensitivity and AUC values. However, its diagnostic reliability decreases in the presence of pancreatic duct stones or severe pancreatitis.

Il testo completo di questo articolo è disponibile in PDF.

Graphical abstract




Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : CP, ERP, IPMN, IPMT, L-EUS, MRCP, PD, RAP, S-MRCP


Mappa


© 2025  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 102 - N° 2

P. 233 - agosto 2025 Ritorno al numero
Articolo precedente Articolo precedente
  • Clinical utility of incorporating next-generation sequencing results in the management algorithm of pancreatic cysts
  • Alex R. Jones, Olgert Bardhi, Patricio Polanco, Daniel Ellis, Christofer Bishop, Veronica Coleman, Blake Foley, Gaurav Khatri, Markus Goldschmiedt, John Mansour, Hendrikus Vanderveldt, Aatur Singhi, Nisa Kubiliun, Tarek Sawas
| Articolo seguente Articolo seguente
  • Future of pancreas divisum diagnosis: linear-array endoscopic ultrasound leads the way
  • Ali A. Siddiqui

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.